World's Best Scientists 2026 revealed!
Maurizio Zazzi

Maurizio Zazzi

D-Index & Metrics

Microbiology

D-Index
47
Citations
8805
World Ranking
4779
National Ranking
153

Maurizio Zazzi publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Maurizio Zazzi sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 344 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Maurizio Zazzi D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Maurizio Zazzi sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 47 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Maurizio Zazzi is affiliated with the University of Siena in Italy. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with specific focus on subfields such as Infectious Diseases, Virology, Epidemiology, Public Health, Environmental and Occupational Health, and Hepatology.

The scientist's publications concentrate on topics including HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Hepatitis C virus research, and Pneumocystis jirovecii pneumonia detection and treatment.

Notable recent papers include:

  • SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19 (2021), published in Expert Opinion on Therapeutic Patents
  • Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge (2020), published in Molecules
  • Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort (2022), published in Clinical Infectious Diseases
  • Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic (2020), published in Viruses
  • Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data From the PRESTIGIO Registry (2020), published in Open Forum Infectious Diseases

The researcher collaborates frequently with others including Ilaria Vicenti, Francesco Saladini, Filippo Dragoni, Maria Mercedes Santoro, and Antonella Castagna.

Common publication venues for their work are:

  • Journal of Antimicrobial Chemotherapy
  • Viruses
  • Preprints.org
  • Open Forum Infectious Diseases
  • Journal of Infection

Best Publications

  • Local epidemics gone viral: Evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC

    Alessia Lai;Francesco Roberto Simonetti;Gaetano Brindicci;Annalisa Bergna

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • A novel methodology for large-scale phylogeny partition

    Mattia C.F. Prosperi;Massimo Ciccozzi;Iuri Fanti;Francesco Saladini

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.

    Giulietta Venturi;Marinunzia Catucci;Laura Romano;Paola Corsi

  • Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents.

    Annalaura Brai;Roberta Fazi;Cristina Tintori;Claudio Zamperini

  • Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models

    Mattia C. F. Prosperi;Mattia C. F. Prosperi;Michal Rosen-Zvi;André Altmann;Maurizio Zazzi

  • SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19

    Ilaria Vicenti;Maurizio Zazzi;Francesco Saladini

  • The development of artificial neural networks to predict virological response to combination HIV therapy.

    Brendan Larder;Dechao Wang;Andrew Revell;Julio Montaner

  • Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens

    A. Marconi;M. Balestrieri;G. Comastri;F.R. Pulvirenti

  • A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy

    Dechao Wang;Brendan Larder;Andrew Revell;Julio Montaner

  • Virologic Failure Following Low-level Viremia and Viral Blips During Antiretroviral Therapy: Results From a European Multicenter Cohort

    Unknown

  • Clinically validated genotype analysis: guiding principles and statistical concerns.

    Françoise Brun-Vézinet;Dominique Costagliola;Mounir Ait Khaled;Vincent Calvez

  • Selecting anti-HIV therapies based on a variety of genomic and clinical factors

    Michal Rosen-Zvi;Andre Altmann;Mattia Prosperi;Ehud Aharoni

  • Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time

    Dineke Frentz;Charles A. B. Boucher;Charles A. B. Boucher;Matthias Assel;Andrea De Luca

  • Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge.

    Francesca Picarazzi;Ilaria Vicenti;Francesco Saladini;Maurizio Zazzi

  • Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study.

    Roberta Gagliardini;Arturo Ciccullo;Alberto Borghetti;Franco Maggiolo

  • Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe

    Andrea De Luca;Andrea De Luca;David Dunn;Maurizio Zazzi;Ricardo Camacho

  • Comparison of classifier fusion methods for predicting response to anti HIV-1 therapy.

    André Altmann;Michal Rosen-Zvi;Mattia Prosperi;Ehud Aharoni

Frequent Co-Authors

Andrea De Luca
Andrea De Luca University of Siena
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Rolf Kaiser
Rolf Kaiser University of Cologne
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Kristel Van Laethem
Kristel Van Laethem Rega Institute for Medical Research
Claudia Balotta
Claudia Balotta University of Milan
Lidia Ruiz
Lidia Ruiz IrsiCaixa
Francesca Ceccherini-Silberstein
Francesca Ceccherini-Silberstein University of Rome Tor Vergata
Carlo Federico Perno
Carlo Federico Perno University of Milan
Fausto Baldanti
Fausto Baldanti University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students pursuing a degree in Microbiology in the USA, exploring related online degrees can broaden career opportunities. One growing field is health information management, which blends healthcare and data management. If you’re interested, consider exploring health information management jobs salary insights to understand potential earnings and growth.

Choosing the right program is crucial, especially for online learning. Accreditation matters, and programs accredited by CAHIIM ensure quality education. You can find the top options by checking out accredited online health information management degree cahiim listings.

If you want to enter the healthcare field quickly, certifications like medical billing and coding are excellent paths. Many institutions offer fast online medical billing and coding certification programs that can be completed in months, opening doors to administrative roles in healthcare.

Moreover, numerous medical degrees are now available online, expanding access to health-related careers. If you're curious about the options, it’s helpful to review what medical degree can i get online to find a program that aligns with your goals.

Best Scientists Citing Maurizio Zazzi

Trending Scientists

Recently Published Articles